Skip to content
Homepage
Clinic directory

5 Best Ketamine Therapy Clinics in Indianapolis, Indiana

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Indianapolis, IN

Ketamine Therapy clinics in Indianapolis

Ketamine therapy in Indianapolis is delivered through psychiatry-led clinics, anesthesia-run infusion centers, and ketamine-assisted psychotherapy practices, with hospital referrals often tied to IU Health, Ascension St Vincent, and Community Health Network. Demand reflects a pharma-industry (Lilly) and insurance-driven patient base and an active local market for treatment-resistant depression, PTSD, and chronic pain.

The strongest evidence supports intranasal esketamine (Spravato, FDA-approved for treatment-resistant depression) and intravenous racemic ketamine (off-label, substantial supporting evidence). Clinics in Indianapolis, Indiana also offer intramuscular, sublingual, and at-home oral lozenge protocols, with weaker evidence and variable safety oversight. Indiana Medical Licensing Board rules on delegation and physician supervision shapes which clinics can operate as cash-pay versus insurance-eligible.

With ketamine clinics on Regenerated.com in Indianapolis, patients can compare whether the clinic offers psychiatric evaluation, anesthesia monitoring during infusion, and structured preparation and integration.

5 Clinics

Axon Health Associates

Indianapolis, IN

Axon Health Associates, an outpatient mental health practice in Indianapolis, specializes in ketamine-assisted therapy for treatment-resistant depression, anxiety, and post-traumatic stress disorder.…

  • Transcranial Magnetic Stimulation (TMS)
  • Ketamine Therapy

Integrated Health Solutions

Indianapolis, IN

Integrated Health Solutions, an IV therapy clinic in Indianapolis, offers a comprehensive menu of custom intravenous protocols designed to support recovery, immune function, energy, and metabolic hea…

  • NAD IV Therapy
  • Vitamin IV Therapy
  • Biofeedback Therapy
  • IV Therapy
  • IV Hydration

Vitality IV Bar

Indianapolis, IN

Vitality IV Bar, an IV therapy clinic in Indianapolis, offers comprehensive intravenous nutrient protocols including Myers Cocktails, NAD+ infusions, high-dose vitamin C, and electrolyte rehydration.…

  • NAD IV Therapy
  • Vitamin IV Therapy
  • IV Therapy
  • IV Hydration
  • Ketamine Therapy

Indy Behavioral Health

Indianapolis, IN

Indy Behavioral Health, an integrative clinic in Indianapolis, offers ketamine therapy and esketamine (Spravato) alongside transcranial magnetic stimulation for treatment-resistant depression, anxiet…

  • Ozone Therapy
  • IV Therapy
  • Transcranial Magnetic Stimulation (TMS)
  • Hyperbaric Oxygen Therapy (HBOT)
  • Ketamine Therapy

Accentus Mental Health

Indianapolis, IN

Accentus Mental Health, a veteran-owned clinic serving greater Indianapolis, specializes in ketamine therapy and esketamine (Spravato®) for treatment-resistant depression, anxiety, and obsessive-comp…

  • Transcranial Magnetic Stimulation (TMS)
  • Ketamine Therapy
15 30 50 results per page

Regulatory context

A note on Indiana's ketamine therapy rules.

Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.

  • SB 139 / Psilocybin Research (2024)
    Authorized clinical research on psilocybin for treatment-resistant mental health conditions at Indiana universities; no therapeutic access framework.
  • Indiana Controlled Substances Act
    Mirrors federal scheduling.

Indiana enforces federal scheduling. The Indiana Medical Licensing Board oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Indiana INSPECT PDMP requires controlled substance reporting.

Ketamine Therapy in Indianapolis, answered.

In Indianapolis, a single IV ketamine infusion typically runs 400 to 700 dollars, with a full 6 session induction protocol at 2,400 to 4,200. Premium clinics on the higher end, more affordable providers on the lower end. Intramuscular ketamine often costs less, around 250 to 500 per session. Compounded ketamine lozenges via telehealth run 250 to 500 per month. Spravato (esketamine) is frequently covered by insurance for treatment resistant depression; out of pocket list price is roughly 600 to 900 per treatment session, with most patients paying a copay.

Ketamine is a Schedule III controlled substance and has been FDA approved as an anesthetic since 1970. Spravato (esketamine), a derivative nasal spray, is FDA approved for treatment resistant depression under a REMS program requiring in clinic administration and post dose monitoring. IV, intramuscular, and compounded oral ketamine for depression, PTSD, and chronic pain are used off label with Emerging to Strong evidence depending on indication. Off label prescribing is legal for DEA registered providers but must follow state and federal controlled substance rules.

Indianapolis ketamine is delivered by MDs and DOs (typically psychiatrists, anesthesiologists, emergency medicine, or pain specialists) holding a DEA registration and Indiana controlled substance authority. Nurse practitioners and physician assistants may prescribe or administer depending on Indiana scope of practice and supervisory rules. Spravato requires a REMS certified clinic and certified prescriber. Verify the provider's DEA registration, board certification, and whether a monitoring clinician is present during infusions.

Yes, with caveats. Mindbloom, Joyous, Innerwell, and similar platforms prescribe compounded ketamine lozenges to Indiana residents through telehealth, subject to the Ryan Haight Act and DEA special registration rules currently in effect. These programs pair at home dosing with virtual integration support and cost roughly 250 to 500 per month. In clinic IV and intramuscular ketamine remain the standard for treatment resistant depression and PTSD and cannot be delivered via telehealth. Spravato always requires in clinic REMS administration.

Verify DEA registration on the DEA Office of Diversion Control registrant lookup and Indiana medical board license status. Confirm board certification in psychiatry, anesthesiology, emergency medicine, or pain medicine. Ask about the monitoring protocol during infusion (vitals, continuous clinician presence), integration therapy options, and the clinic's crisis and safety plan. Check whether the clinic is Spravato REMS certified if that is your treatment path. Be cautious of providers who skip screening, push large prepaid packages, or offer take home IV ketamine.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology